CONMED EBITDA Margin 2010-2024 | CNMD

Current and historical EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization) margin for CONMED (CNMD) over the last 10 years. The current EBITDA margin for CONMED as of March 31, 2024 is .
CONMED EBITDA Margin Historical Data
Date TTM Revenue TTM EBITDA EBITDA Margin
2024-03-31 $1.26B $0.22B 17.51%
2023-12-31 $1.25B $0.20B 15.98%
2023-09-30 $1.17B $0.15B 12.57%
2023-06-30 $1.14B $0.14B 12.29%
2023-03-31 $1.10B $0.14B 12.39%
2022-12-31 $1.05B $0.14B 13.78%
2022-09-30 $1.07B $0.18B 17.23%
2022-06-30 $1.04B $0.19B 18.04%
2022-03-31 $1.02B $0.19B 18.82%
2021-12-31 $1.01B $0.19B 19.19%
2021-09-30 $0.99B $0.18B 18.38%
2021-06-30 $0.98B $0.19B 19.00%
2021-03-31 $0.88B $0.14B 15.76%
2020-12-31 $0.86B $0.13B 15.30%
2020-09-30 $0.88B $0.14B 15.54%
2020-06-30 $0.87B $0.13B 14.70%
2020-03-31 $0.95B $0.17B 17.67%
2019-12-31 $0.96B $0.16B 17.07%
2019-09-30 $0.93B $0.15B 16.52%
2019-06-30 $0.90B $0.14B 15.33%
2019-03-31 $0.88B $0.13B 14.86%
2018-12-31 $0.86B $0.13B 15.48%
2018-09-30 $0.84B $0.13B 15.60%
2018-06-30 $0.83B $0.13B 15.94%
2018-03-31 $0.81B $0.13B 15.64%
2017-12-31 $0.80B $0.11B 13.17%
2017-09-30 $0.78B $0.09B 11.95%
2017-06-30 $0.77B $0.09B 12.03%
2017-03-31 $0.77B $0.09B 11.44%
2016-12-31 $0.76B $0.09B 12.32%
2016-09-30 $0.75B $0.09B 12.27%
2016-06-30 $0.73B $0.09B 12.26%
2016-03-31 $0.72B $0.09B 12.60%
2015-12-31 $0.72B $0.10B 13.21%
2015-09-30 $0.72B $0.10B 13.69%
2015-06-30 $0.73B $0.09B 11.93%
2015-03-31 $0.74B $0.09B 12.36%
2014-12-31 $0.74B $0.10B 13.24%
2014-09-30 $0.75B $0.10B 13.10%
2014-06-30 $0.75B $0.11B 13.96%
2014-03-31 $0.76B $0.11B 14.00%
2013-12-31 $0.76B $0.11B 13.91%
2013-09-30 $0.76B $0.11B 13.95%
2013-06-30 $0.76B $0.11B 14.55%
2013-03-31 $0.76B $0.11B 14.61%
2012-12-31 $0.77B $0.11B 14.60%
2012-09-30 $0.75B $0.11B 15.03%
2012-06-30 $0.74B $0.11B 15.34%
2012-03-31 $0.74B $0.11B 15.35%
2011-12-31 $0.73B $0.11B 15.45%
2011-09-30 $0.72B $0.11B 14.66%
2011-06-30 $0.72B $0.11B 14.54%
2011-03-31 $0.72B $0.10B 14.31%
2010-12-31 $0.71B $0.10B 13.88%
2010-09-30 $0.72B $0.10B 13.47%
2010-06-30 $0.72B $0.09B 12.03%
2010-03-31 $0.71B $0.08B 10.89%
2009-12-31 $0.70B $0.07B 10.07%
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $2.281B $1.245B
CONMED Corporation is a major medical products manufacturer specializing in surgical instruments and devices for minimally invasive procedures and monitoring. A significant portion of the company's revenues are derived from products designed for the orthopedic surgery markets of arthroscopy and powered surgical instruments. The company also sells products for general and other surgical specialties such as electrosurgery systems for all types of surgery, and endosurgery instruments for minimally invasive laparoscopic surgery. Patient Care products, including ECG electrodes for heart monitoring and pulse oximetry for blood oxygenation monitoring, are provided for various clinical settings.The company operates in two revenue segments: Orthopedic Surgery and General Surgery.
Stock Name Country Market Cap PE Ratio
McKesson (MCK) United States $72.887B 20.45
Becton Dickinson (BDX) United States $66.122B 18.71
West Pharmaceutical Services (WST) United States $24.159B 43.30
Cardinal Health (CAH) United States $23.477B 13.43
Align Technology (ALGN) United States $19.244B 37.15
Cooper (COO) United States $18.860B 28.54
Labcorp (LH) United States $16.830B 14.49
Henry Schein (HSIC) United States $9.184B 16.34
DENTSPLY SIRONA (XRAY) United States $5.702B 14.76
Merit Medical Systems (MMSI) United States $4.760B 26.09
Patterson (PDCO) United States $2.145B 10.27
STAAR Surgical (STAA) United States $2.022B 77.66
Atrion (ATRI) United States $0.815B 43.51
Lifevantage (LFVN) United States $0.096B 12.34
Pro-Dex (PDEX) United States $0.067B 34.03
Biolase (BIOL) United States $0.006B 0.00